Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Posttraumatic Stress Disorder

Status: Not yet recruiting

Phase of Trial: Phase II/III

Latest Information Update: 06 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NBTX 001 (Primary)
Indications Post-traumatic stress disorders
Focus Therapeutic Use
Sponsors Nobilis Therapeutics

Most Recent Events

02 Mar 2021 Planned initiation date changed from 1 Dec 2020 to 31 May 2021.
10 Sep 2020 Planned initiation date changed from 1 Jul 2020 to 1 Dec 2020.
28 Feb 2020 Planned End Date changed from 1 Dec 2020 to 1 Jul 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com